Aggerbeck L. P., Wetterau J. R., Weisgraber K. H., Wu C.-S. C., and Lindgren F. T. (1988) Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains. J. Biol. Chem.263, 6249–6258. PubMedCAS Google Scholar
Aoki K., Uchihara T., Sanjo N., Nakamura A., Ikeda K., Tsuchiya K., et al. (2003) Increased expression of neuronal apolipoprotein E in human brain with cerebral infarction. Stroke34, 875–880. PubMedCAS Google Scholar
Bales K.R., Verina T., Cummins D. J., Du Y., Dodel R. C., Saura J., et al. (1999) Apolipoprotein E is essential for amyloid deposition in the APPV717F transgenic mouse model of Alzheimer’s disease. Proc. Natl. Acad. Sci. USA96, 15233–15238. PubMedCAS Google Scholar
Bao F., Arai H., Matsushita S., Higuchi S., and Sasaki H. (1996) Expression of apolipoprotein E in normal and diverse neurodegenerative disease brain. Neuroreport7, 1733–1739. PubMedCAS Google Scholar
Basu S. K., Brown M. S., Ho Y. K., Havel R. J., and Goldstein J. L. (1981) Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E. Proc. Natl. Acad. Sci. USA78, 7545–7549. PubMedCAS Google Scholar
Beffert U. and Poirier J. (1996) Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer’s disease. Ann. N. Y. Acad. Sci.777, 166–174. PubMedCAS Google Scholar
Bellosta S., Nathan B. P., Orth M., Dong L.-M., Mahley R. W., and Pitas R. E. (1995) Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J. Biol. Chem.270, 27063–27071. PubMedCAS Google Scholar
Biernat J., Mandelkow E.-M., Schröter C., Lichtenberg-Kraag B., Steiner B., Berling B., et al. (1992) The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J.11, 1593–1597. PubMedCAS Google Scholar
Boschert U., Merlo-Pich E., Higgins G., Roses A. D., and Catsicas S. (1999) Apolipoprotein E expression by neurons surviving excitotoxic stress. Neurobiol. Dis.6, 508–514. PubMedCAS Google Scholar
Boyles J. K., Pitas R. E., Wilson E., Mahley R. W., and Taylor J. M. (1985) Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest.76, 1501–1513. PubMedCAS Google Scholar
Boyles J. K., Zoellner C. D., Anderson L. J., Kosik L. M., Pitas R. E., Weisgraber K. H., et al. (1989) A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J. Clin. Invest.83, 1015–1031. PubMedCAS Google Scholar
Brecht W. J., Harris F. M., Chang S., Tesseur I., Liu G.-Q., Xu, Q., et al. (2004) Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J. Neurosci.24, 2527–2534. PubMedCAS Google Scholar
Buttini M., Akeefe H., Lin C., Mahley R. W., Pitas R. E., Wyss-Coray T., et al. (2000) Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. Neuroscience97, 207–210. PubMedCAS Google Scholar
Buttini M., Orth M., Bellosta S., Akeefe H., Pitas R. E., Wyss-Coray T., et al. (1999) Expression of human apolipoprotein E3 or E4 in the brains of Apoe −/− mice: isoform-specific effects on neurodegeneration. J. Neurosci.19, 4867–4880. PubMedCAS Google Scholar
Buttini M., Yu G.-Q., Shockley K., Huang Y., Jones B., Masliah E., et al. (2002) Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid β peptides but not on plaque formation. J. Neurosci.22, 10539–10548. PubMedCAS Google Scholar
Cedazo-Mínguez A., Hamker U., Meske V., Veh R. W., Hellweg R., Jacobi C., et al. (2001) Regulation of apolipoprotein E secretion in rat primary hippocampal astrocyte cultures. Neuroscience105, 651–661. PubMed Google Scholar
Cho H. S., Hyman B. T., Greenberg S. M., and Rebeck G. W. (2001) Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Aβ aggregation. J. Neuropathol. Exp. Neurol.60, 342–349. PubMedCAS Google Scholar
Corder E. H., Saunders A. M., Strittmatter W.J., Schmechel D. E., Gaskell P. C., Small G. W., et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science261, 921–923. PubMedCAS Google Scholar
Dekroon R. M. and Armati P. J. (2001) Synthesis and processing of apolipoprotein E in human brain cultures. Glia33, 298–305. PubMedCAS Google Scholar
DeMattos R. B., Curtiss L. K., and Williams D. L. (1998) A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins. J. Biol. Chem.273, 4206–4212. PubMedCAS Google Scholar
DeMattos R. B., Rudel L. L., and Williams D. L. (2001) Biochemical analysis of cell-derived apoE3 particles active in stimulating neurite outgrowth. J. Lipid Res.42, 976–987. PubMedCAS Google Scholar
Diedrich J. F., Minnigan H., Carp R. I., Whitaker J. N., Race R., Frey W. II, and Haase A. T. (1991) Neuropathological changes in scrapie and Alzheimer’s disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J. Virol.65, 4759–4768. PubMedCAS Google Scholar
Dong L.-M. and Weisgraber K. H. (1996) Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J. Biol. Chem.271, 19053–19057. PubMedCAS Google Scholar
Dong L.-M., Wilson C., Wardell M.R., Simmons T., Mahley R. W., Weisgraber K. H., et al. (1994) Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J. Biol. Chem.269, 22358–22365. PubMedCAS Google Scholar
Drouet B., Fifre A., Pinçon-Raymond M., Vandekerckhove J., Rosseneu M., Guéant J.-L., et al. (2001) ApoE protects cortical neurones against neuro- toxicity induced by the non-fibrillar C-terminal domain of the amyloid-β peptide. J. Neurochem.76, 117–127. PubMedCAS Google Scholar
Dupont-Wallois L., Soulié C., Sergeant N., Wavrant-de Wrieze N., Chartier-Harlin M.- C., et al. (1997) ApoE synthesis in human neuroblastoma cells. Neurobiol. Dis.4, 356–364. PubMedCAS Google Scholar
Elshourbagy N. A., Liao W. S., Mahley R. W., and Taylor J. M. (1985) Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc. Natl. Acad. Sci. USA82, 203–207. PubMedCAS Google Scholar
Estus S., Tucker H. M., van Rooyen C., Wright S., Brigham E. F., Wogulis M., et al. (1997) Aggregated amyloid-β protein induces cortical neuronal apoptosis and concomitant “apoptotic” pattern of gene induction. J. Neurosci.17, 7736–7745. PubMedCAS Google Scholar
Fagan A. M., Bu G., Sun Y., Daugherty A., and Holtzman D. M. (1996) Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J. Biol. Chem.271, 30121–30125. PubMedCAS Google Scholar
Fagan A. M., Holtzman D. M., Munson G., Mathur T., Schneider D., Chang L. K., et al. (1999) Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice. J. Biol. Chem.274, 30001–30007. PubMedCAS Google Scholar
Farrer L. A., Cupples L. A., Haines J. L., Hyman B., Kukull W. A., Mayeux R., et al. (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. JAMA278, 1349–1356. PubMedCAS Google Scholar
Ferreira S., Dupire M.-J., Delacourte A., Najib J., and Caillet-Boudin M.-L. (2000) Synthesis and regulation of apolipoprotein E during the differentiation of human neuronal precursor NT2/D1 cells into postmitotic neurons. Exp. Neurol.166, 415–421. PubMedCAS Google Scholar
Friedhoff P., von Bergen M., Mandelkow E.-M., and Mandelkow E. (2000) Structure of tau protein and assembly into paired helical filaments. Biochim. Biophys. Acta1502, 122–132. PubMedCAS Google Scholar
Goedert M., Spillantini M. G., Cairns N. J., and Crowther R. A. (1992) Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron8, 159–168. PubMedCAS Google Scholar
Gong J.-S., Kobayashi M., Hayashi H., Zou K., Sawamura N., Fujita S. C., et al. (2002) Apolipoprotein E (apoE) isoform-dependent lipid release from astrocytes prepared from human apoE3 and apoE4 knock-in mice. J. Biol. Chem.277, 29919–29926. PubMedCAS Google Scholar
Gregg R. E., Zech L. A., Schaefer E. J., Stark D., Wilson D., and Brewer H. B., Jr. (1986) Abnormal in vivo metabolism of apolipoprotein E4 in humans. J. Clin. Invest.78, 815–821. PubMedCAS Google Scholar
Grehan S., Allan C., Tse E., Walker D., and Taylor J. M. (2001a) Expression of the apolipoprotein E gene in the skin is controlled by a unique downstream enhancer. J. Invest. Dermatol.116, 77–84. PubMedCAS Google Scholar
Grehan S., Tse E., and Taylor J. M. (2001b) Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain. J. Neurosci.21, 812–822. PubMedCAS Google Scholar
Han S.-H., Einstein G., Weisgraber K. H., Strittmatter W. J., Saunders A. M., Pericak-Vance M., et al. (1994) Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study. J. Neuropathol. Exp. Neurol.53, 535–544. PubMedCAS Google Scholar
Handelmann G. E., Boyles J. K., Weisgraber K. H., Mahley R. W., and Pitas R. E. (1992) Effects of apolipoprotein E, β-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J. Lipid Res.33, 1677–1688. PubMedCAS Google Scholar
Hardy J. and Selkoe D. J. (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science297, 353–356. PubMedCAS Google Scholar
Harris F. M., Brecht W. J., Xu Q., Tesseur I., Kekonius L., Wyss-Coray T., et al. (2003) Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc. Natl. Acad. Sci. USA100, 10966–10971. PubMedCAS Google Scholar
Harris F. M., Tesseur I., Brecht W. J., Xu Q., Mullendorf K., Chang S., et al. (2004) Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer’s disease. J. Biol. Chem.279, 3862–3868. PubMedCAS Google Scholar
Hartman R. E., Wozniak D. F., Nardi A., Olney J. W., Sartorius L., and Holtzman D. M. (2001) Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer’s-like neuropathology. Exp. Neurol.170, 326–344. PubMedCAS Google Scholar
Hebert L. E., Scherr P. A., Bienias J. L., Bennett D. A., and Evans D. A. (2003) Alzheimer disease in the US population. Prevalence estimates using the 2000 census. Arch. Neurol.60, 1119–1122. PubMed Google Scholar
Herz J. and Beffert U. (2000) Apolipoprotein E receptors: linking brain development and Alzheimer’s disease. Nat. Rev. Neurosci.1, 51–58. PubMedCAS Google Scholar
Holtzman D. M., Bales K. R., Tenkova T., Fagan A. M., Parsadanian M., Sartorius L. J., et al. (2000a) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer’s disease. Proc. Natl. Acad. Sci. USA97, 2892–2897. PubMedCAS Google Scholar
Holtzman D. M., Fagan A. M., Mackey B., Tenkova T., Sartorius L., Paul S. M., et al. (2000b) Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer’s disease model. Ann. Neurol.47, 739–747. PubMedCAS Google Scholar
Holtzman D. M., Pitas R. E., Kilbridge J., Nathan B., Mahley R. W., Bu G., et al. (1995) Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. Natl. Acad. Sci. USA92, 9480–9484. PubMedCAS Google Scholar
Huang Y. and Mahley R. W. (1999) Apolipoprotein E and human disease, in Plasma Lipids and Their Role in Disease, Barter, P. J., and Rye, K.-A., eds., Harwood Academic Publishers, Amsterdam, The Netherlands, pp. 257–284. Google Scholar
Huang Y., Liu X. Q., Wyss-Coray T., Brecht W. J., Sanan D. A., and Mahley R. W. (2001) Apolipoprotein E fragments present in Alzheimer’s disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc. Natl. Acad. Sci. USA98, 8838–8843. PubMedCAS Google Scholar
Ignatius M. J., Gebicke-Härter P. J., Skene J. H. P., Schilling J. W., Weisgraber K. H., Mahley R. W., et al. (1986) Expression of apolipoprotein E during nerve degeneration and regeneration. Proc. Natl. Acad. Sci. USA83, 1125–1129. PubMedCAS Google Scholar
Ignatius M. J., Shooter E. M., Pitas R. E., and Mahley R. W. (1987) Lipoprotein uptake by neuronal growth cones in vitro. Science236, 959–962. PubMedCAS Google Scholar
Innerarity T. L., Mahley R. W., Weisgraber K. H., and Bersot T. P. (1978) Apoprotein (E-A-II) complex of human plasma lipoproteins. II. Receptor binding activity of a high density lipoprotein subfraction modulated by the apo(E-A-II) complex. J. Biol. Chem.253, 6289–6295. PubMedCAS Google Scholar
Irizarry M. C., Cheung B. S., Rebeck G. W., Paul S. M., Bales K. R., and Hyman B. T. (2000) Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid β-peptide deposition in homozygous APPV717F transgenic mice. Acta Neuropathol.100, 451–458. PubMedCAS Google Scholar
Jacobsen J. S. (2002) Alzheimer’s disease: an overview of current and emerging therapeutic strategies. Curr. Top. Med. Chem.2, 343–352. PubMedCAS Google Scholar
Ji Y., Permanne B., Sigurdsson E. M., Holtzman D. M., and Wisniewski T. (2001) Amyloid β40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic mice. J. Alzheimers Dis.3, 23–30. PubMedCAS Google Scholar
Ji Z.-S., Miranda R. D., Newhouse Y. M., Weisgraber K. H., Huang Y., and Mahley R. W. (2002) Apolipoprotein E4 potentiates amyloid β peptide-induced lysosomal leakage and apoptosis in neuronal cells. J. Biol. Chem.277, 21821–21828. PubMedCAS Google Scholar
Jordán J., Galindo M. F., Miller R. J., Reardon C. A., Getz G. S., and LaDu M. J. (1998) Isoform-specific effect of apolipoprotein E on cell survival and β-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J. Neurosci.18, 195–204. PubMed Google Scholar
LaDu M. J., Falduto M. T., Manelli A. M., Reardon C. A., Getz G. S., and Frail D. E. (1994) Isoform-specific binding of apolipoprotein E to β-amyloid. J. Biol. Chem.269, 23403–23406. PubMedCAS Google Scholar
LaDu M. J., Pederson T. M., Frail D. E., Reardon C. A., Getz G. S., and Falduto M. T. (1995) Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid. J. Biol. Chem.270, 9039–9042. PubMedCAS Google Scholar
Lauderback C. M., Kanski J., Hackett J. M., Maeda N., Kindy M. S., and Butterfield D. A. (2002) Apolipoprotein E modulates Alzheimer’s Aβ(1–42)-induced oxidative damage to synaptosomes in an allele-specific manner. Brain Res.924, 90–97. PubMedCAS Google Scholar
LeBlanc A. C. and Poduslo J. F. (1990) Regulation of apolipoprotein E gene expression after injury of the rat sciatic nerve. J. Neurosci. Res.25, 162–171. PubMedCAS Google Scholar
LeBlanc A., Liu H., Goodyer C., Bergeron C., and Hammond J. (1999) Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer’s disease. J. Biol. Chem.274, 23426–23436. PubMedCAS Google Scholar
Lesuisse C., Xu G., Anderson J., Wong M., Jankowsky J., Holtz G., et al. (2001) Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice. Hum. Mol. Genet.10, 2525–2537. PubMedCAS Google Scholar
Lewis J., McGowan E., Rockwood J., Melrose H., Nacharaju P., Slegtenhorst M. V., et al. (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet.25, 402–405. PubMedCAS Google Scholar
Ljungberg M. C., Dayanandan R., Asuni A., Rupniak T. H., Anderton B. H., and Lovestone S. (2002) Truncated apoE forms tangle-like structures in a neuronal cell line. Neuroreport13, 867–870. PubMedCAS Google Scholar
Loo D. T., Copani A., Pike C. J., Whittemore E. R., Walencewicz A. J., and Cotman C. W. (1993) Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA90, 7951–7955. PubMedCAS Google Scholar
Lovestone S., Anderton B. H., Hartley K., Jensen T. G., and Jorgensen A. L. (1996) The intracellular fate of apolipoprotein E is tau dependent and apoe allele-specific. Neuroreport7, 1005–1008. PubMedCAS Google Scholar
Ma J., Yee A., Brewer H. B., Jr., Das S., and Potter H. (1994) Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature372, 92–94. PubMedCAS Google Scholar
Mahley R. W. (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science240, 622–630. PubMedCAS Google Scholar
Mahley R. W. and Huang Y. (1999) Apolipoprotein E: from atherosclerosis to Alzheimer’s disease and beyond. Curr. Opin. Lipidol.10, 207–217. PubMedCAS Google Scholar
Mahley R. and Huang Y. (2003) Apolipoprotein E: structure and function in lipid metabolism and neurobiology, in The Molecular and Genetic Basis of Neurologic and Psychiatric Disease, 3rd ed., Rosenberg, R. N., Prusiner, S. B., DiMauro, S., Barchi, R. L., and Nestler, E. J., eds., Butterworth Heinemann, Philadelphia, PA, pp. 565–573. Google Scholar
Mahley R. W. and Rall S. C., Jr. (2000) Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet.1, 507–537. PubMedCAS Google Scholar
Mahley R. W., Nathan B. P., Bellosta S., and Pitas R. E. (1995) Apolipoprotein E: impact of cytoskeletal stability in neurons and the relationship to Alzheimer’s disease. Curr. Opin. Lipidol.6, 86–91. PubMedCAS Google Scholar
Marques M. A., Tolar M., Harmony J. A. K., and Crutcher K. A. (1996) A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity. Neuroreport7, 2529–2532. PubMedCAS Google Scholar
Martel C. L., Mackic J. B., Matsubara E., Governale S., Miguel C., Miao W., et al. (1997) Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer’s amyloid β. J. Neurochem.69, 1995–2004. PubMedCAS Google Scholar
Masliah E., Mallory M., Ge N., Alford M., Veinbergs I., and Roses A. D. (1995) Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol.136, 107–122. PubMedCAS Google Scholar
Mazur-Kolecka B., Frackowiak J., Kowal D., Krzeslowska J., and Dickson D. (2002) Oxidative protein damage in cells engaged in β-amyloidosis is related to apoE genotype. Neuroreport13, 465–468. PubMedCAS Google Scholar
Messmer-Joudrier S., Sagot Y., Mattenberger L., James R. W., and Kato A. C. (1996) Injury-induced synthesis and release of apolipoprotein E and clusterin from rat neural cells. Eur. J. Neurosci.8, 2652–2661. PubMedCAS Google Scholar
Metzger R. E., LaDu M. J., Pan J. B., Getz G. S., Frail D. E., and Falduto M. T. (1996) Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: implications for Alzheimer’s disease. J. Neuropathol. Exp. Neurol.55, 372–380. PubMedCAS Google Scholar
Miyata M. and Smith J. D. (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nat. Genet.14, 55–61. PubMedCAS Google Scholar
Moir R. D., Atwood C. S., Romano D. M., Laurans M. H., Huang X., Bush A. I., et al. (1999) Differential effects of apolipoprotein E isoforms on metal-induced aggregation of Aβ using physiological concentrations. Biochemistry38, 4595–4603. PubMedCAS Google Scholar
Morishima Y., Gotoh Y., Zieg J., Barrett T., Takano H., Flavell R., et al. (2001) β-Amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J. Neurosci.21, 7551–7560. PubMedCAS Google Scholar
Morrow J. A., Hatters D. M., Lu B., Höchtl P., Oberg K. A., Rupp B., et al. (2002) Apolipoprotein E4 forms a molten globule: a potential basis for its association with disease. J. Biol. Chem.277, 50380–50385. PubMedCAS Google Scholar
Morrow J. A., Segall M. L., Lund-Katz S., Phillips M. C., Knapp M., Rupp B., et al. (2000) Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. Biochemistry39, 11657–11666. PubMedCAS Google Scholar
Mulder M., Blokland A., van den Berg D.-J., Schulten H., Bakker A. H. F., Terwel D., et al. (2001) Apolipoprotein E protects against neuropathology induced by a high-fat diet and maintains the integrity of the blood-brain barrier during aging. Lab. Invest.81, 953–960. PubMedCAS Google Scholar
Müller H. W., Gebicke-Härter P. J., Hangen D. H., and Shooter E. M. (1985) A specific 37,000-dalton protein that accumulates in regenerating but not in nonregenerating mammalian nerves. Science228, 499–501. PubMed Google Scholar
Müller H. W., Ignatius M. J., Hangen D. H., and Shooter E. M. (1986) Expression of specific sheath cell proteins during peripheral nerve growth and regeneration in mammals. J. Cell Biol.102, 393–402. PubMed Google Scholar
Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B. A., and Yuan J. (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature403, 98–103. PubMedCAS Google Scholar
Namba Y., Tomonaga M., Kawasaki H., Otomo E., and Ikeda K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res.541, 163–166. PubMedCAS Google Scholar
Nathan B. P., Bellosta S., Sanan D. A., Weisgraber K. H., Mahley R. W., and Pitas R. E. (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science264, 850–852. PubMedCAS Google Scholar
Nathan B. P., Chang K.-C., Bellosta S., Brisch E., Ge N., Mahley R. W., et al. (1995a) The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J. Biol. Chem.270, 19791–19799. PubMedCAS Google Scholar
Nathan B. P., Chang K.-C., Bellosta S., Mahley R. W., and Pitas R. E. (1995b) The inhibition of neurite outgrowth by apolipoprotein E4 is mediated through the low density lipoprotein receptor-related protein. Soc. Neurosci.21(Part 2), 1009 (abstract). Google Scholar
Nicoll J. A. R., Roberts G. W., and Graham D. I. (1996) Amyloid β-protein, APOE genotype and head injury. Ann. N. Y. Acad. Sci.777, 271–275. PubMedCAS Google Scholar
Pasinetti G. M., Hassler M., Stone D., and Finch C. E. (1999) Glial gene expression during aging in rat striatum and in long-term responses to 6-OHDA lesions. Synapse31, 278–284. PubMedCAS Google Scholar
Pastor P., Roe C. M., Villegas A., Bedoya G., Chakraverty S., García G., et al. (2003) Apolipoprotein Eε4 modifies Alzheimer’s disease onset in an E280A PS1 kindred. Ann. Neurol.54, 163–169. PubMedCAS Google Scholar
Pillot T., Goethals M., Najib J., Labeur C., Lins L., Chambaz J., et al. (1999) β-Amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: relevance to Alzheimer’s disease. J. Neurochem.72, 230–237. PubMedCAS Google Scholar
Pitas R. E., Boyles J. K., Lee S. H., Foss D., and Mahley R. W. (1987a) Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta917, 148–161. PubMedCAS Google Scholar
Pitas R. E., Boyles J. K., Lee S. H., Hui D., and Weisgraber K. H. (1987b) Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J. Biol. Chem.262, 14352–14360. PubMedCAS Google Scholar
Poirier J., Delisle M.-C., Quirion R., Aubert I., Farlow M., Lahiri D., et al. (1995) Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc. Natl. Acad. Sci. USA92, 12260–12264. PubMedCAS Google Scholar
Poirier J., Hess M., May P. C., and Finch C. E. (1991) Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol. Brain Res.11, 97–106. PubMedCAS Google Scholar
Raber J., Bongers G., LeFevour A., Buttini M., and Mucke L. (2002) Androgens protect against apolipoprotein E4-induced cognitive deficits. J. Neurosci.22, 5204–5209. PubMedCAS Google Scholar
Raber J., Wong D., Buttini M., Orth M., Bellosta S., Pitas R. E., et al. (1998) Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc. Natl. Acad. Sci. USA95, 10914–10919. PubMedCAS Google Scholar
Raber J., Wong D., Yu G.-Q., Buttini M., Mahley R. W., Pitas R. E., et al. (2000) Apolipoprotein E and cognitive performance. Nature404, 352–354. PubMedCAS Google Scholar
Raffaï R. L., Dong L.-M., Farese R. V., Jr., and Weisgraber K. H. (2001) Introduction of human apolipoprotein E4 “domain interaction” into mouse apolipoprotein E. Proc. Natl. Acad. Sci. USA98, 11587–11591. PubMed Google Scholar
Rall S. C., Jr., Weisgraber K. H., Innerarity T. L., and Mahley R. W. (1982a) Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects. Proc. Natl. Acad. Sci. USA79, 4696–4700. PubMedCAS Google Scholar
Rall S. C., Jr., Weisgraber K. H., and Mahley R. W. (1982b) Human apolipoprotein E. The complete amino acid sequence. J. Biol. Chem.257, 4171–4178. PubMedCAS Google Scholar
Rapoport M., Dawson H. N., Binder L. I., Vitek M. P., and Ferreira A. (2002) Tau is essential to β-amyloid-induced neurotoxicity. Proc. Natl. Acad. Sci. USA99, 6364–6369. PubMedCAS Google Scholar
Romas S. N., Santana V., Williamson J., Ciappa A., Lee J. H., Rondon H. Z., et al. (2002) Familial Alzheimer disease among Caribbean Hispanics. A reexamination of its association with APOE. Arch. Neurol.59, 87–91. PubMed Google Scholar
Roses A. D. (1996) Apolipoprotein E alleles as risk factors in Alzheimer’s disease. Annu. Rev. Med.47, 387–400. PubMedCAS Google Scholar
Sanan D. A., Weisgraber K. H., Russell S. J., Mahley R. W., Huang D., Saunders A., et al. (1994) Apolipoprotein E associates with β amyloid peptide of Alzheimer’s disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. J. Clin. Invest.94, 860–869. PubMedCAS Google Scholar
Saunders A. M., Strittmatter W. J., Schmechel D., St George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., et al. (1993) Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer’s disease. Neurology43, 1467–1472. PubMedCAS Google Scholar
Saura J., Petegnief V., Wu X., Liang Y., and Paul S. M. (2003) Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide. J. Neurochem.85, 1455–1467. PubMedCAS Google Scholar
Schneider A., Biernat J., von Bergen M., Mandelkow E., and Mandelkow E.-M. (1999) Phosphorylation that detaches tau protein from microtubules (Ser262,Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry38, 3549–3558. PubMedCAS Google Scholar
Selkoe D. J. (2001) Clearing the brain’s amyloid cobwebs. Neuron32, 177–180. PubMedCAS Google Scholar
Shibata M., Yamada S., Kumar S. R., Calero M., Bading J., Frangione B., et al. (2000) Clearance of Alzheimer’s amyloid-β1–40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest.106, 1489–1499. PubMedCAS Google Scholar
Shih S.-J., Allan C., Grehan S., Tse E., Moran C., and Taylor J. M. (2000) Duplicated downstream enhancers control expression of the human apolipoprotein E gene in macrophages and adipose tissue. J. Biol. Chem.275, 31567–31572. PubMedCAS Google Scholar
Skene J. H. P. and Shooter E. M. (1983) Denervated sheath cells secrete a new protein after nerve injury. Proc. Natl. Acad. Sci. USA80, 4169–4173. PubMedCAS Google Scholar
Soulié C., Mitchell V., Dupont-Wallois L., Chartier-Harlin M.-C., Beauvillain J.-C., Delacourte A., et al. (1999) Synthesis of apolipoprotein E (apoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and apoE. Eeurosci. Lett.265, 147–150. Google Scholar
Steinmetz A., Jakobs C., Motzny S., and Kaffarnik H. (1989) Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins. Arteriosclerosis9, 405–411. PubMedCAS Google Scholar
Strittmatter W. J., Saunders A. M., Goedert M., Weisgraber K. H., Dong L.-M., Jakes R., et al. (1994a) Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc. Natl. Acad. Sci. USA91, 11183–11186. PubMedCAS Google Scholar
Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., et al. (1993a) Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA90, 1977–1981. PubMedCAS Google Scholar
Strittmatter W. J., Weisgraber K. H., Goedert M., Saunders A. M., Huang D., Corder E. H., et al. (1994b) Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp. Neurol.125, 163–171. PubMedCAS Google Scholar
Strittmatter W. J., Weisgraber K. H., Huang D. Y., Dong L.-M., Salvesen G. S., Pericak-Vance M., et al. (1993b) Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA90, 8098–8102. PubMedCAS Google Scholar
Sun Y., Wu G., Onifade M. K., Patel S. N., LaDu M. J., et al. (1998) Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J. Neurosci.18, 3261–3272. PubMedCAS Google Scholar
Tang M.-X., Stern Y., Marder K., Bell K., Gurland B., Lantigua R., et al. (1998) The _APOE_-ε4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA279, 751–755. PubMedCAS Google Scholar
Tesseur I., Van Dorpe J., Bruynseels K., Bronfman F., Sciot R., Van Lommel A., et al. (2000b) Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. Am. J. Pathol.157, 1495–1510. PubMedCAS Google Scholar
Tesseur I., Van Dorpe J., Spittaels K., Van den Haute C., Moechars D., and Van Leuven F. (2000a) Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. Am. J. Pathol.156, 951–964. PubMedCAS Google Scholar
Tolar M., Keller J. N., Chan S., Mattson M. P., Marques M. A., and Crutcher K. A. (1999) Truncated apolipoprotein E (apoE) causes increased intracellular calcium and may mediate apoE neurotoxicity. J. Neurosci.19, 7100–7110. PubMedCAS Google Scholar
Tolar M., Marques M. A., Harmony J. A. K., and Crutcher K. A. (1997) Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated. J. Neurosci.17, 5678–5686. PubMedCAS Google Scholar
Troy C. M., Rabacchi S. A., Friedman W. J., Frappier T. F., Brown K., and Shelanski M. L. (2000) Caspase-2 mediates neuronal cell death induced by β-amyloid. J. Neurosci.20, 1386–1392. PubMedCAS Google Scholar
Troy C. M., Rabacchi S. A., Xu Z., Maroney A. C., Connors T. J., Shelanski M. L., et al. (2001) β-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation. J. Neurochem.77, 157–164. PubMedCAS Google Scholar
Uetsuki T., Takemoto K., Nishimura I., Okamoto M., Niinobe M., Momoi T., et al. (1999) Activation of neuronal caspase-3 by intracellular accumulation of wild-type Alzheimer amyloid precursor protein. J. Neurosci.19, 6955–6964. PubMedCAS Google Scholar
Utermann G., Langenbeck U., Beisiegel U., and Weber W. (1980) Genetics of the apolipoprotein E system in man. Am. J. Hum. Genet.32, 339–347. PubMedCAS Google Scholar
Utermann G., Steinmetz A., and Weber W. (1982) Genetic control of human apolipoprotein E polymorphism: comparison of one- and two-dimensional techniques of isoprotein analysis. Hum. Genet.60, 344–351. PubMedCAS Google Scholar
Vincent B. and Smith J. D. (2001) Astrocytes down-regulate neuronal β-amyloid precursor protein expression and modify its processing in an apolipoprotein E isoform-specific manner. Eur. J. Neurosci.14, 256–266. PubMedCAS Google Scholar
Weisgraber K. H. (1990) Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. J. Lipid Res.31, 1503–1511. PubMedCAS Google Scholar
Weisgraber K. H. (1994) Apolipoprotein E: structure-function relationships. Adv. Protein Chem.45, 249–302. PubMedCAS Google Scholar
Weisgraber K. H. and Mahley R. W. (1978) Apoprotein (E-A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. J. Biol. Chem.253, 6281–6288. PubMedCAS Google Scholar
Weisgraber K. H. and Mahley R. W. (1996) Human apolipoprotein E: the Alzheimer’s disease connection. FASEB J.10, 1485–1494. PubMedCAS Google Scholar
Weisgraber K. H. and Shinto L. H. (1991) Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity. J. Biol. Chem.266, 12029–12034. PubMedCAS Google Scholar
Weisgraber K. H., Pitas R. E., and Mahley R. W. (1994a) Lipoproteins, neurobiology, and Alzheimer’s disease: structure and function of apolipoprotein E. Curr. Opin. Struct. Biol.4, 507–515. CAS Google Scholar
Weisgraber K. H., Rall S. C. Jr., and Mahley R. W. (1981) Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J. Biol. Chem.256, 9077–9083. PubMedCAS Google Scholar
Weisgraber K. H., Roses A. D., and Strittmatter W. J. (1994b) The role of apolipoprotein E in the nervous system. Curr. Opin. Lipidol.5, 110–116. PubMedCAS Google Scholar
Werb Z. and Chin J. R. (1983) Onset of apoprotein E secretion during differentiation of mouse bone marrow-derived mononuclear phagocytes. J. Cell Biol.97, 1113–1118. PubMedCAS Google Scholar
Wetterau J. R., Aggerbeck L. P., Rall S. C. Jr., and Weisgraber K. H. (1988) Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains. J. Biol. Chem.263, 6240–6248. PubMedCAS Google Scholar
Wilson C., Wardell M. R., Weisgraber K. H., Mahley R. W., and Agard D. A. (1991) Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science252, 1817–1822. PubMedCAS Google Scholar
Wisniewski T. and Frangione B. (1992) Applipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett.135, 235–238. PubMedCAS Google Scholar
Wisniewski T., Castaño E. M., Golabek A., Vogel T., and Frangione B. (1994) Acceleration of Alzheimer’s fibril formation by apolipoprotein E in vitro. Am. J. Pathol.145, 1030–1035. PubMedCAS Google Scholar
Xu P.-T., Gilbert J. R., Qiu H.-L., Ervin J., Rothrock-Christian T. R., Hulette C., et al. (1999a) Specificregional transcription of apolipoprotein E in human brain neurons. Am. J. Pathol.154, 601–611. PubMedCAS Google Scholar
Xu P.-T., Gilbert J. R., Qiu H.-L., Rothrock-Christian T., Settles D. L., Roses A. D., et al. (1998) Regionally specific neuronal expression of human APOE gene in transgenic mice. Neurosci. Lett.246, 65–68. PubMedCAS Google Scholar
Xu P.-T., Schmechel D., Qiu H.-L., Herbstreith M., Rothrock-Christian T., Eyster M., et al. (1999b) Sialylated human apolipoprotein E (apoEs) is preferentially associated with neuron-enriched cultures from APOE transgenic mice. Neurobiol. Dis.6, 63–75. PubMedCAS Google Scholar
Xu, P.-T., Schmechel D., Rothrock-Christian T., Burkhart D. S., Qiu H.-L., Popko B., et al. (1996) Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice. Neurobiol. Dis.3, 229–245. PubMedCAS Google Scholar
Yankner B. A., Dawes L. R., Fisher S., Villa-Komaroff L., Oster-Granite M. L., and Neve R. L. (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer’s disease. Science245, 417–420. PubMedCAS Google Scholar
Zannis V. I. and Breslow J. L. (1981) Human very lowdensity lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. Biochemistry20, 1033–1041. PubMedCAS Google Scholar
Zannis V. I., Just P. W., and Breslow J. L. (1981) Human apolipoprotein E isoprotein subclasses are genetically determined. Am. J. Hum. Genet.33, 11–24. PubMedCAS Google Scholar